Q2 2026 Holdings
Filed 2026-08-14 | 45 holdings | $624.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $205.1M | 2,104,184 | 32.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $99.4M | 1,398,948 | 15.9% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $72.4M | 760,424 | 11.6% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $37.8M | 1,700,708 | 6.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $27.9M | 550,000 | 4.5% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $21.5M | 6,299,999 | 3.4% |
| Aktis Oncology Inc(AKTS) | COM | 01021M104 | $15.6M | 484,200 | 2.5% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $10.7M | 70,000 | 1.7% |
| Mobia MED Inc(MOBI) | COMMON STOCK | 60705V103 | $10.7M | 798,282 | 1.7% |
| Repligen Corp(RGEN) | COM | 759916109 | $10.6M | 77,800 | 1.7% |
| Immunic Inc(IMUX) | COM NEW | 4525EP200 | $10.3M | 669,941 | 1.6% |
| Senseonics Hldgs Inc(SENS) | COM | 81727U303 | $9.1M | 1,600,000 | 1.5% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $9.0M | 924,487 | 1.4% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $6.8M | 200,000 | 1.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.7M | 100,000 | 1.1% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $6.1M | 105,000 | 1.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $5.5M | 70,000 | 0.9% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $5.3M | 519,300 | 0.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $5.3M | 98,000 | 0.8% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $4.2M | 42,000 | 0.7% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $3.9M | 265,934 | 0.6% |
| Nuvectis Pharma Inc(NVCT) | COM | 67080T108 | $3.7M | 200,000 | 0.6% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.7M | 24,000 | 0.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $3.4M | 80,000 | 0.5% |
| Satellos Bioscience Inc(MSLE) | COM | 80401L803 | $3.0M | 387,769 | 0.5% |
| Alamar Biosciences Inc(ALMR) | COMMON STOCK | 010911105 | $3.0M | 110,000 | 0.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $2.8M | 4,998,267 | 0.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $2.5M | 20,000 | 0.4% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $2.3M | 10,000 | 0.4% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $2.2M | 200,000 | 0.3% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $2.0M | 60,000 | 0.3% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $1.8M | 80,000 | 0.3% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $1.4M | 50,000 | 0.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $1.3M | 75,000 | 0.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.2M | 80,000 | 0.2% |
| Oddity Tech LTD(ODD) | SHS CL A | M7518J104 | $1.1M | 70,000 | 0.2% |
| Scynexis Inc(SCYX) | COM | 811292309 | $1.1M | 260,206 | 0.2% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $996.8K | 75,000 | 0.2% |
| Abbott Laboratories(ABT) | COM | 002824100 | $907.4K | 10,000 | 0.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $744.8K | 10,000 | 0.1% |
| Peloton Interactive Inc(PTON) | CL A COM | 70614W100 | $591.0K | 100,000 | 0.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $433.2K | 15,000 | 0.1% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $334.2K | 43,853 | 0.1% |
| Savara Inc(SVRA) | COM | 805111101 | $308.0K | 50,000 | 0.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $124.2K | 6,660 | 0.0% |